US EditionEuroPCR 2025: Thirty-day results show promise for Lux-Valve Plus TTVR system - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
EuroPCR 2025: Thirty-day results show promise for Lux-Valve Plus TTVR system - Cardiovascular News
Thomas Modine Jenscare has announced the release of 30-day follow-up results of the TRINITY trial of the LuX-Valve Plus transcatheter tricuspid valve replacement (TTVR) system, presented at EuroPCR 2025 (20–23 May, Paris, France) by Thomas Modine (CHU de Bordeaux, Bordeaux, France). TRINITY is a global prospective, multicentre, single-arm clinical trial, which primarily aims to evaluate the safety and efficacy of LuX-Valve Plus patients with sev…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
